Literature DB >> 29872954

Altered microRNA expression signature in Chikungunya-infected mammalian fibroblast cells.

Deepti Parashar1, Mandar S Paingankar2,3, Ashwini More2, Poonam Patil2, Sarika Amdekar2.   

Abstract

Chikungunya virus (CHIKV) infection can cause severe arthralgia and chronic arthritis in humans. MicroRNAs (miRNA) have demonstrated their potential use as biomarker in variety of human pathologies and infections. This study was conducted to understand the miRNA signature in early CHIKV infection stages. In the current study, we used TaqMan-based quantitative PCR method to identify the miRNA signature of host response upon CHIKV infection in human and mouse fibroblast cells. The GO enrichment analysis suggests that the putative target genes of these differentially expressed miRNAs are to be involved in RIG-I pathway, TGF-beta-signaling pathway, JAK-STAT-signaling pathway, MAPK-signaling pathway, cytokine-cytokine receptor interactions, and Fc gamma R-mediated phagocytosis. The results obtained in the current study and earlier studies indicate the potential use of miR15, miR-16, miR-17, let-7e, miR-125, miR-99, and miR-23a as a biomarker in CHIKV infection. miRNAs such as miR-15a, miR-16, miR-140, miR-146a, miR-155, miR203, miR223, miR-499, and miR-363 which are implicated in rheumatoid arthritis showed differential regulation in CHIKV infection. The data obtained in this study provide valuable information on CHIKV-induced miRNA expression in mammalian fibroblast cells, and suggest that CHIKV may establish infection by regulating miRNA expression profile.

Entities:  

Keywords:  Arthralgia; CHIKV infection; Functional enrichment; MicroRNA profiling; Target prediction

Mesh:

Substances:

Year:  2018        PMID: 29872954     DOI: 10.1007/s11262-018-1578-8

Source DB:  PubMed          Journal:  Virus Genes        ISSN: 0920-8569            Impact factor:   2.332


  54 in total

1.  MicroRNA miR-125a controls hematopoietic stem cell number.

Authors:  Shangqin Guo; Jun Lu; Rita Schlanger; Hao Zhang; Judy Y Wang; Michelle C Fox; Louise E Purton; Heather H Fleming; Bradley Cobb; Matthias Merkenschlager; Todd R Golub; David T Scadden
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-08       Impact factor: 11.205

2.  Genetic divergence of Chikungunya viruses in India (1963-2006) with special reference to the 2005-2006 explosive epidemic.

Authors:  Vidya A Arankalle; Shubham Shrivastava; Sarah Cherian; Rashmi S Gunjikar; Atul M Walimbe; Santosh M Jadhav; A B Sudeep; Akhilesh C Mishra
Journal:  J Gen Virol       Date:  2007-07       Impact factor: 3.891

3.  Chikungunya virus nonstructural protein 2 inhibits type I/II interferon-stimulated JAK-STAT signaling.

Authors:  Jelke J Fros; Wen Jun Liu; Natalie A Prow; Corinne Geertsema; Maarten Ligtenberg; Dana L Vanlandingham; Esther Schnettler; Just M Vlak; Andreas Suhrbier; Alexander A Khromykh; Gorben P Pijlman
Journal:  J Virol       Date:  2010-08-04       Impact factor: 5.103

4.  Cluster analysis and display of genome-wide expression patterns.

Authors:  M B Eisen; P T Spellman; P O Brown; D Botstein
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-08       Impact factor: 11.205

5.  miR-146a facilitates replication of dengue virus by dampening interferon induction by targeting TRAF6.

Authors:  Siyu Wu; Li He; Yuye Li; Tinglong Wang; Lianqiang Feng; Lifang Jiang; Ping Zhang; Xi Huang
Journal:  J Infect       Date:  2013-05-16       Impact factor: 6.072

6.  Chronic joint disease caused by persistent Chikungunya virus infection is controlled by the adaptive immune response.

Authors:  David W Hawman; Kristina A Stoermer; Stephanie A Montgomery; Pankaj Pal; Lauren Oko; Michael S Diamond; Thomas E Morrison
Journal:  J Virol       Date:  2013-10-16       Impact factor: 5.103

7.  Birth and expression evolution of mammalian microRNA genes.

Authors:  Julien Meunier; Frédéric Lemoine; Magali Soumillon; Angélica Liechti; Manuela Weier; Katerina Guschanski; Haiyang Hu; Philipp Khaitovich; Henrik Kaessmann
Journal:  Genome Res       Date:  2012-10-03       Impact factor: 9.043

8.  MicroRNA regulation and its effects on cellular transcriptome in human immunodeficiency virus-1 (HIV-1) infected individuals with distinct viral load and CD4 cell counts.

Authors:  Karolina Duskova; Pruthvi Nagilla; Hai-Son Le; Priyadarshini Iyer; Anbupalam Thalamuthu; Jeremy Martinson; Ziv Bar-Joseph; William Buchanan; Charles Rinaldo; Velpandi Ayyavoo
Journal:  BMC Infect Dis       Date:  2013-05-30       Impact factor: 3.090

9.  An outbreak of chikungunya in Jamshedpur, Jharkhand in 2011.

Authors:  Y K Gurav; V Gopalkrishna; P S Shah; D R Patil; M Mishra; M S Paingankar; A Singh; P S Sathe; A C Mishra
Journal:  Indian J Med Res       Date:  2012-11       Impact factor: 2.375

10.  Administration of E2 and NS1 siRNAs inhibit chikungunya virus replication in vitro and protects mice infected with the virus.

Authors:  Deepti Parashar; Mandar S Paingankar; Satyendra Kumar; Mangesh D Gokhale; A B Sudeep; Sapana B Shinde; V A Arankalle
Journal:  PLoS Negl Trop Dis       Date:  2013-09-05
View more
  3 in total

1.  Chikungunya virus time course infection of human macrophages reveals intracellular signaling pathways relevant to repurposed therapeutics.

Authors:  Madison Gray; Israel Guerrero-Arguero; Antonio Solis-Leal; Richard A Robison; Bradford K Berges; Brett E Pickett
Journal:  PeerJ       Date:  2022-03-21       Impact factor: 2.984

Review 2.  Disease Resolution in Chikungunya-What Decides the Outcome?

Authors:  Priyanshu Srivastava; Ankit Kumar; Abdul Hasan; Divya Mehta; Ramesh Kumar; Chetan Sharma; Sujatha Sunil
Journal:  Front Immunol       Date:  2020-04-28       Impact factor: 7.561

Review 3.  Role of MicroRNAs in Bone Pathology during Chikungunya Virus Infection.

Authors:  Enakshi Roy; Siddappa N Byrareddy; St Patrick Reid
Journal:  Viruses       Date:  2020-10-23       Impact factor: 5.048

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.